Anuchit Chutaputti

Peginterferon α‐2a (40 kDa): an advance in the treatment of hepatitis B e antigen‐positive chronic hepatitis B

W. G. E. Cooksley, Teerha Piratvisuth, Shin‐Da Lee et al. · Journal of Viral Hepatitis · 2003 · 476 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Hepatitis B Virus of Genotype B with or without Recombination with Genotype C over the Precore Region plus the Core Gene

Fuminaka Sugauchi, Etsuro Orito, Takafumi Ichida et al. · Journal of Virology · 2002 · 298 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

What are the risk factors and settings for non‐alcoholic fatty liver disease in Asia–Pacific?

Jian‐Gao Fan, Toshiji Saibara, Shivakumar Chitturi et al. · Journal of Gastroenterology and Hepatology · 2007 · 270 citations

Medicine, Endocrinology, Health Sciences +17

Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C

Fuminaka Sugauchi, Etsuro Orito, Takafumi Ichida et al. · Gastroenterology · 2003 · 205 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +9

Baseline characteristics and early on-treatment response predict the outcomes of 2years of telbivudine treatment of chronic hepatitis B

Stefan Zeuzem, Edward Gane, Yun‐Fan Liaw et al. · Journal of Hepatology · 2009 · 195 citations

Medicine, Pharmacology, Pharmacotherapy +16